News | Press Release
June 28, 2013
TOSHIBA CARDIAC ULTRASOUND IMPROVES VISUALIZATION, DIAGNOSTIC ACCURACY
The Aplio 500 CV and 300 CV are premier systems for all 2D cardiovascular exams. The systems feature Toshiba’s 2D Wall Motion Tracking technology, providing exceptional visualization and quantitative analysis of myocardial wall motion with unrivaled accuracy and reproducibility.
Through the use of on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal), Toshiba’s Aplio CV systems are designed to provide comprehensive information at the patient’s bedside.
Lunch & Learn Sessions were hosted by three presenters discussing their experiences using Toshiba’s cardiovascular ultrasound systems:
- Hans Joachim Nesser, M.D., Elisabethinen Teaching Hospital, Linz, Austria
- John Gorcsan III, M.D., Pittsburgh, Pa.
- Gul H. Dadlani, M.D., All Children’s Hospital, St. Petersburg, Fla.
In Canada, a series of Echocardiography Seminars were held earlier in Toronto and Ottawa on June 7th and 8th. The seminars were hosted by Dr. Bijoy Khandheria from Aurora Health Care, Milwaukee, Wisconsin. Dr. Khandheria presented a review of technological advances in “Cardio oncology-established and the emerging role of speckle tracking” while using Toshiba’s CV Ultrasound system and 2D Wall Motion Tracking. Seminar participants experienced a live demonstration of on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal). The seminar was well received with favourable assessments of the performance of the Aplio CV systems with respect to imaging quality, ergonomics, patient access and workflow.
“Toshiba’s cardiovascular ultrasound systems provide the industry’s highest-resolution images with the ability to deliver crucial clinical data in real time,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba.
About Toshiba of Canada Limited, Medical Systems Division
With headquarters in Markham, Ontario, Toshiba of Canada Limited, Medical Systems Division (TCL), markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in Canada. For more information, visit the TCL Medical Systems Division website at www.toshiba-medical.ca
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
About Toshiba
Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society. Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.
